Eikon Therapeutics, Inc. (EIKN)
7.26
-0.98
(-11.89%)
USD |
NASDAQ |
Oct 23, 16:00
7.24
-0.02
(-0.28%)
After-Hours: 20:00
Eikon Therapeutics Market Cap : 393.12M for Oct. 23, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 23, 2026 | 393.12M |
| October 22, 2026 | 446.19M |
| October 21, 2026 | 433.19M |
| October 20, 2026 | 442.94M |
| October 19, 2026 | 416.95M |
| October 16, 2026 | 401.78M |
| October 15, 2026 | 408.28M |
| October 14, 2026 | 379.58M |
| October 13, 2026 | 363.88M |
| October 12, 2026 | 393.12M |
| October 09, 2026 | 404.49M |
| October 08, 2026 | 406.12M |
| October 07, 2026 | 408.28M |
| October 06, 2026 | 406.66M |
| October 05, 2026 | 408.28M |
| October 02, 2026 | 396.91M |
| October 01, 2026 | 401.24M |
| September 30, 2026 | 435.36M |
| September 29, 2026 | 428.32M |
| September 28, 2026 | 428.32M |
| September 25, 2026 | 428.86M |
| September 24, 2026 | 448.89M |
| September 23, 2026 | 440.23M |
| September 22, 2026 | 486.26M |
| September 21, 2026 | 478.13M |
| Date | Value |
|---|---|
| September 18, 2026 | 484.63M |
| September 17, 2026 | 465.68M |
| September 16, 2026 | 460.81M |
| September 15, 2026 | 513.87M |
| September 14, 2026 | 506.83M |
| September 11, 2026 | 484.09M |
| September 10, 2026 | 498.71M |
| September 09, 2026 | 581.02M |
| September 08, 2026 | 579.93M |
| September 04, 2026 | 588.06M |
| September 03, 2026 | 593.47M |
| September 02, 2026 | 616.21M |
| September 01, 2026 | 589.14M |
| August 31, 2026 | 566.40M |
| August 28, 2026 | 594.55M |
| August 27, 2026 | 623.80M |
| August 26, 2026 | 648.70M |
| August 25, 2026 | 679.57M |
| August 24, 2026 | 604.30M |
| August 21, 2026 | 616.76M |
| August 20, 2026 | 582.10M |
| August 19, 2026 | 650.33M |
| August 18, 2026 | 630.83M |
| August 17, 2026 | 566.94M |
| August 14, 2026 | 598.35M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.396B |
| Alnylam Pharmaceuticals, Inc. | 29.96B |
| Anika Therapeutics, Inc. | 286.66M |
| Savara, Inc. | 866.79M |
| Vericel Corp. | 2.176B |
Market Cap Related Metrics
| PEG Ratio | -0.008 |
| Price to Book Value | 0.8427 |
| Price | 7.26 |
| Earnings Yield | -90.63% |
| PEGY Ratio | -0.008 |